Uneingeschränkter Zugang

Parathyroidectomy in a patient treated with emicizumab

Helen Hupston

Helen Hupston

University Hospital, Queen Elizabeth Hospital BirminghamBirmingham, UK
Orcid-Profil
Suche nach diesem Autor auf
Sciendo|Google Scholar
Hupston, Helen
  
23. Dez. 2019
Parathyroidectomy in a patient treated with emicizumab's Cover Image
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zitieren
COVER HERUNTERLADEN
Online veröffentlicht: 23. Dez. 2019
Seitenbereich: 51 - 53
DOI: https://doi.org/10.17225/jhp00149
Schlüsselwörter
© 2019 Helen Hupston, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
1 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, Vorklinische Medizin, Grundlagenmedizin, andere, Klinische Medizin, Klinische Medizin, andere, Pharmazie, Pharmakologie
Zeitschrift RSS Feed